Scientists described the use of two chemical modifications, incorporating a neuropilin receptor agonist peptide and a hypoxia-responsive lipid for targeting and release of an encapsulated drug from bovine milk exosomes toTNBC cells.
[ACS Applied Bio Materials]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
174079
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
